Centene forecast adjusted 2026 earnings above $3 a share, even as medical costs rise and government payments remain under pressure.

Two of the oldest holdings in the portfolio of India’s Warren Buffett Nemish Shah’s portfolio are in the news again, thanks ...

Centene Corporation is upgraded to a Buy due to strong revenue growth in 2025 and 2026 guidance. Learn more about CNC stock ...

Centene reported a $1.1 billion fourth quarter loss as the health insurer struggles with rising healthcare costs in the ...

Centene outperformed in the fourth quarter, while predicting earnings growth in 2026 — a rarity among managed care companies’ generally dour outlooks.

Line Man Wongnai is moving ahead with plans to raise funds as it intends to boost investment in its fintech unit, Lineman Pay Read more at The Business Times.

Centene Corporation has closed the books on a difficult 2025, a period marked by elevated medical costs and significant ...